List of works by Wendy B London

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.

scientific article published on 18 June 2018

A Feasibility Study Evaluating Extraoral Photobiomodulation Therapy for Prevention of Mucositis in Pediatric Hematopoietic Cell Transplantation

scientific article

A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.

scientific article published on 06 December 2016

A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma

scientific article published on 02 November 2020

A Retrospective Multicenter Study of Fatal Pediatric Melanoma

scientific article published on 01 July 2020

A finite mixture survival model to characterize risk groups of neuroblastoma

scientific article

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency

scientific article

A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project

scientific article published on 18 November 2020

A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1

scientific article published on 21 January 2013

A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study

scientific article published in October 2012

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

scientific article published on 07 July 2009

ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.

scientific article

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma

scientific article

APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial

scientific article

Activating mutations in ALK provide a therapeutic target in neuroblastoma

scientific article

Advances in Risk Classification and Treatment Strategies for Neuroblastoma

scientific article

Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project

scientific article published on 21 April 2020

Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group

scientific article

Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group

scientific article published on December 2009

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study

scientific article

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

scientific article

Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study

scientific article published on 29 July 2019

Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study

scientific article

Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group

scientific article published on April 2008

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

scientific article published on 11 July 2017

Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma

scientific article

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism.

scientific article

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study

scientific article

Balancing education and service in graduate medical education: data from pediatric trainees and program directors

scientific article

CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression

scientific article

CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas

scientific article published on 24 June 2008

Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project

scientific article

Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: A report from the INRG project

scientific article published on 01 December 2011

Characteristics of non-melanoma skin cancer in children without identifiable risk factors

scientific article published on 17 July 2020

Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency

scientific article published on 03 July 2020

Children's Oncology Group's 2013 blueprint for research: neuroblastoma

scientific article published on 19 December 2012

Chromosome 1p and 11q deletions and outcome in neuroblastoma

scientific article

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma

scientific article

Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project

scientific article

Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group

scientific article published on February 2008

Clinical significance of NTRK family gene expression in neuroblastomas

scientific article published on 11 October 2011

Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma

scientific article published on 27 August 2012

Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project

scientific article

Clinicopathologic features and long-term outcomes of NUT midline carcinoma

scientific article

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

scientific article published on October 2009

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

scientific article

Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations

scientific article published on 20 February 2020

Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group

scientific article

Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

scientific article published on 21 May 2019

Copy number variation at 1q21.1 associated with neuroblastoma

scientific article

Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group

scientific article published on 01 April 2019

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931

scientific article published on 16 July 2018

Criteria for optimizing prognostic risk groups in pediatric cancer: analysis of data from the Children's Oncology Group

scientific article

Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center

scientific article

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531

scientific article published on 16 November 2018

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group

scientific article published on 21 August 2018

Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaboration

scientific article

Development of an open-source, flexible framework for interinstitutional data sharing and collaboration.

scientific article published in 2012

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease

scientific article published on 01 February 2007

Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study

scientific article published on 01 October 2006

EPN-14PEDIATRIC EPENDYMOMA: MULTI-INSTITUTIONAL EXPERIENCE REVEALS POOR LONG-TERM OVERALL SURVIVAL DESPITE FAVORABLE FIVE-YEAR OUTCOMES.

scientific article published on 30 May 2016

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial

scientific article published on 01 August 2019

Effect of weight on outcomes of children undergoing hematopoietic cell transplantation

scientific article

Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study

scientific article published on 01 June 2004

End-of-Life Care Patterns Associated with Pediatric Palliative Care among Children Who Underwent Hematopoietic Stem Cell Transplant

scientific article published on 19 February 2016

Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects

scientific article

Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group

scientific article

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

article

Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children's Cancer Group/Pediatric Oncology Group

scientific article published on 01 March 2003

Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.

scientific article

Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology Group

scientific article published on 28 June 2012

Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analyses

scientific article published in June 2008

Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitors

scientific article published on 01 October 2020

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

scientific article published on 5 March 2018

Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency

scientific article published on 11 February 2020

Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.

scientific article published on 8 October 2010

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project

scientific article published on 17 May 2011

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

scientific article

Health Literacy and Clinical Outcomes Following Hematopoietic Stem-Cell Transplantation

scientific article published on 21 January 2022

Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1

scientific article

Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.

scientific article published on 8 September 2017

Hyperdiploidy Plus NonamplifiedMYCNConfers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study

article

Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project

scientific article published on 28 December 2015

Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report

scientific article published on 12 October 2014

Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma

scientific article

Incidence and causes of hospital readmission in pediatric patients after hematopoietic cell transplantation

scientific article

Influence of neuroblastoma stage on serum-based detection of MYCN amplification

scientific article

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma

scientific article published on 01 January 2019

Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients

scientific article

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

scientific article

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number

scientific article published on 01 June 2006

Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma

scientific article published on June 2006

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

scientific article published on May 2009

International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.

scientific article

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial

Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group

scientific article published on 28 April 2020

Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial

scientific article

Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database

scientific article

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

scientific article

Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project

scientific article

MB-66PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHLDREN WITH Wnt POSITIVE STANDARD RISK MEDULLOBLASTOMA.

scientific article published on 30 May 2016

MEDU-34. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA

scientific article published on 23 April 2019

MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of Dyskerin.

scientific article published on 13 April 2016

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group

scientific article published on 15 December 2017

MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN

scientific article published on 01 November 2000

MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.

scientific article published on 19 July 2016

Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531

scientific article published on 06 August 2019

Malignant mediastinal germ cell tumors: an intergroup study.

scientific article

Malignant retroperitoneal and abdominal germ cell tumors: an intergroup study.

scientific article

Mechanisms of CHD5 Inactivation in neuroblastomas

scientific article published on 31 January 2012

Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database

scientific article

Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome

scientific article

Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation

scientific article published on 08 April 2022

Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study.

scientific article published on 28 January 2016

N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastoma.

scientific article published on 27 December 2011

Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study

scientific article

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

scientific article published on 2 October 2017

Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project

scientific article

Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group

scientific article

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

scientific article published on 26 December 2016

Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study

scientific article published on 6 January 2016

Non-malignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children.

scientific article published on 24 March 2018

Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency

scientific article published on 12 June 2018

ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma

scientific article

One- and two-stage designs for stratified phase II clinical trials

scientific article published in September 2005

Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group

scientific article published on 13 January 2014

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma

scientific article

Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.

scientific article

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group

scientific article published on January 2009

Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy

scientific article published in December 2005

Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group

scientific article published on December 2008

Overcoming reprogramming resistance of Fanconi anemia cells

scientific article

POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group

scientific article published in June 2006

Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation

scientific article published on 8 November 2016

Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors.

scientific article

Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement.

scientific article published on 12 September 2012

Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group

scientific article

Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee

scientific article

Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study

scientific article

Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study

scientific article

Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group

scientific article published on 9 September 2011

Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study

scientific article published on 17 October 2011

Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease

scientific article published on 05 December 2020

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

scientific article

Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)

scientific article published on 01 April 2019

Predictors of neoplastic disease in children with isolated pituitary stalk thickening.

scientific article

Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.

scientific article published on February 2005

Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families

scientific article published on 23 October 2014

Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study

scientific article published on 13 September 2018

Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study.

scientific article published in June 2006

Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor).

scientific article published on 11 August 2009

Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database

scientific article

Prognostic significance ofEPHB6, EFNB2, andEFNB3 expressions in neuroblastoma

scientific article published on 01 December 2000

Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.

scientific article published on 3 October 2011

Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children's Oncology Group ANBL0532 Study

scientific article published on 12 June 2020

Provider Perspectives on Use of Medical Marijuana in Children With Cancer

scientific article published on 12 December 2017

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

scientific article published on 25 July 2013

Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials

scientific article published on 06 August 2020

Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study

scientific article

Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Grou

scientific article

Reply to J. Stenman et al.

scientific article

Reply to K. Beiske et al

scientific article published on 15 September 2020

Reply to N.-K.V. Cheung et al

scientific article published on 17 November 2014

Response Evaluation Criteria in Solid Tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma

scientific article

Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: a pediatric oncology group study

scientific article published in October 2004

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group

scientific article

Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.

scientific article

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting

scientific article published on 4 May 2017

Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults

scientific article published on 15 May 2019

Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation

scientific article published on 3 April 2017

Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study

scientific article published on 09 April 2019

SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings

scientific article published on 21 March 2015

Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study

scientific article published on 27 October 2017

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project

scientific article

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group

scientific article

Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma

scientific article

Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database

scientific article published in December 2008

Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.

scientific article

Sleep dysfunction in long term survivors of craniopharyngioma

scientific article published on 19 April 2012

Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System

scientific article published on 01 December 2018

Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients

scientific article published on 01 October 2018

Sun exposure and protection practices in children after allogeneic hematopoietic stem cell transplantation: A Survey-Based Cross-Sectional Cohort Study

scientific article published on 13 August 2019

Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group

scientific article published on July 2006

Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future

scientific article published on 01 October 2020

The Effectiveness of a Hospital-Based School Liaison Program: A Comparative Study of Parental Perception of School Supports for Children With Pediatric Cancer and Neurofibromatosis Type 1

scientific article published on 30 March 2018

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

scientific article published on December 2008

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report

scientific article published in December 2008

The challenge of defining "ultra-high-risk" neuroblastoma

scientific article published on 26 November 2018

The clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.

scientific article published on 16 March 2018

The effect of neoadjuvant chemotherapy and surgery in children with malignant germ cell tumors of the genital region: a pediatric intergroup trial.

scientific article published in June 2003

The genetic landscape of high-risk neuroblastoma

scientific article published on 20 January 2013

The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

scientific article published on 30 May 2020

The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency

scientific article published on 28 May 2020

The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives

scientific article

The use of central laboratories and remote electronic data capture to risk-adjust therapy for pediatric acute lymphoblastic leukemia and neuroblastoma

scientific article

Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).

scientific article published on 18 December 2013

Trajectory of Material Hardship and Income Poverty in Families of Children Undergoing Chemotherapy: A Prospective Cohort Study

scientific article published on 23 September 2015

Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival

scientific article published on 14 December 2012

Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience

scientific article

Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.

scientific article published in September 2004

Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study

scientific article published in February 2006

Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study

scientific article published in August 2002

Tumor histology during induction therapy in patients with high-risk neuroblastoma.

scientific article published on 11 December 2011

Use and Effectiveness of Gonadotropin-Releasing Hormone Agonists for Prophylactic Menstrual Suppression in Postmenarchal Women Who Undergo Hematopoietic Cell Transplantation

scientific article

Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system

scientific article published on 31 January 2014

Voriconazole phototoxicity in children: a retrospective review

scientific article

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival

scientific article

miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

scientific article

microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma

scientific article

p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.

scientific article published in November 2001

Paulina is supported by:

About Paulina

Help